Clinical trial for Smoking Cessation
Official title Tobacco Education and Lung Health Study (TEAL)
ClinicalTrials.gov ID: NCT06290869
What this study is testing
- What it's testing
- This study is testing whether one smoking‑help method works better than another for people who are having lung cancer screening. It also looks at how many people use each method and how much it costs.
- Who it's for
- You may be able to join if you are a smoker who is getting a lung cancer screening test.
- What's involved
- You will try one of two smoking‑help programs. You will have visits and may fill out questionnaires and give a breath or saliva sample to check if you are still smoking.
- Time commitment
- The study lasts about six months, with visits at the start, at three months, and at six months to check your progress.
- Phase 3: a large, late-stage study
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- eligible for a screening or diagnostic scan,
- USPSTF eligibility criteria (50-80 years old and \>20-pack years);
- currently smoking cigarettes (\>1 in the past 30 days);
- English speaking;
- able to provide meaningful consent.
You likely can't join if
- prior lung cancer,
- hearing impairment,
- cognitive impairment,
- household member already enrolled.
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.